New Scientific Paper Published

Dear colleagues,

It is a pleasure to announce that a new scientific paper has been published:

Manenti, Gugliemo, Tommaso Perretta, Marco Nezzo, Federico Romeo Fraioli, Beatrice Carreri, Paola Elda Gigliotti, Andrea Micillo, Andrea Malizia, Daniele Di Giovanni, Colleen Patricia Ryan, and Francesco Giuseppe Garaci (2024). "Transperineal Laser Ablation (TPLA) Treatment of Focal Low–Intermediate Risk Prostate Cancer" Cancers 16, no. 7: 1404. https://doi.org/10.3390/cancers16071404

Abstract:

Over the past few years, there has been a notable escalation in scholarly attention towards the implementation of focal therapeutic interventions for patients diagnosed with low- and intermediate-risk prostate cancer in order to achieve long-term cancer control and reduce morbidity associated with surgery and radiation therapy. This interventional pilot study (ClinicalTrials.gov ID NCT04045756) aimed to evaluate the short/medium-term (3 years) efficacy of trans perineal laser ablation (TPLA) in treating the index lesion of low–intermediate-risk prostate cancer, along with assessing the safety of the procedure and Quality of Life (QoL) of patients. Our results suggested that TPLA is a safe, feasible and effective treatment of low–intermediate-risk prostate cancer, with a high rate of tumor eradication and preservation of Quality of Life.

Congratulation to all the authors.

STAY TUNED!